R2R managing director, Ralf Jahns Germany is set to enter an era of digital health over next few years, making it a significant market for health tech solutions. Digital health analysis and consultancy firm Research2Guidance (R2G) has published a white paper examining the challenges and opportunities, in light of Germany’s new digital health application (DiGA) fast track approval process. To gain DiGA approval, providers must prove to the German Federal Institute for Drugs and Medical Devices (BfArM), that their apps can improve patient care and meet specified criteria. However, R2G’s report says that attaining DiGA status alone is not enough to ensure success in the German market and providers must also develop a comprehensive market entry strategy to drive adoption. It recommends measures such as providing high quality clinical evidence, selecting distribution channels and planning provider outreach.